Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancerSong Yi Bae, Sang Kook Lee|Oncotarget|2015Cited by 76
Measurement and models accounting for cell death capture hidden variation in compound responseSong Yi Bae, Aaron S. Meyer|Cell Death and Disease|2020Cited by 18
ZBTB7A as a novel vulnerability in neuroendocrine prostate cancerSong Yi Bae, Justin M. Drake|Frontiers in Endocrinology|2023Cited by 6
Dissecting signaling regulators driving AXL-mediated bypass resistance and associated phenotypes by phosphosite perturbationsMarc Creixell, Aaron S. Meyer, Jacqueline Gerritsen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1